AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9041901 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls (N=60)
Number of subjects: 181
Study 8924310 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg/day)
Number of subjects: 108
Study 8924310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 2350520 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest (no exercise)
Number of subjects: 6
Study 2350520 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 42% of VO2, max
Number of subjects: 6
Study 2350520 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 61% of VO2, max
Number of subjects: 6
Study 2350520 — intervention group
Group type: COMPARATOR
Intervention: Exercise at 80% of VO2, max
Number of subjects: 6
Study 386698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g/day for 6 weeks
Number of subjects: 30
Study 386698 — intervention group
Group type: COMPARATOR
Intervention: Gefarnate 250 mg/day for 6 weeks
Number of subjects: 30
Study 31129617 — intervention group
Group type: EXPERIMENTAL
Intervention: Early activation of thoracic epidural anesthesia (EA TEA)
Number of subjects: 50
Study 31129617 — intervention group
Group type: COMPARATOR
Intervention: Late activation of thoracic epidural anesthesia (LA TEA)
Number of subjects: 50
Study 28614270 — intervention group
Group type: EXPERIMENTAL
Intervention: CTU group
Number of subjects: 100
Study 28614270 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 23543334 — intervention group
Group type: EXPERIMENTAL
Intervention: Strattice™
Number of subjects: 172
Study 23543334 — intervention group
Group type: COMPARATOR
Intervention: Ultrapro
Number of subjects: 172
Study 22573127 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil 10 mg (up-titrated to 20 and 40 mg)
Number of subjects: 1453
Study 22573127 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 2.5 mg (up-titrated to 5 and 10 mg)
Number of subjects: 1453
Study 22573127 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil
Number of subjects: 1453
Study 22573127 — intervention group
Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 1453
Study 20083382 — intervention group
Group type: EXPERIMENTAL
Intervention: Genuine acupuncture
Number of subjects: 18
Study 20083382 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 18
Study 18420368 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Number of subjects: 12
Study 18420368 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 12
Study 15867334 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy and diet (n = 5)
Number of subjects: 37
Study 15867334 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 4)
Number of subjects: 37
Study 15867334 — intervention group
Group type: COMPARATOR
Intervention: BED subjects compared to nonbinge eating normals (NB)
Number of subjects: 37
Study 14692469 — intervention group
Group type: EXPERIMENTAL
Intervention: zaleplon 10 mg
Number of subjects: 23
Study 14692469 — intervention group
Group type: EXPERIMENTAL
Intervention: zopiclone 7.5 mg
Number of subjects: 23
Study 14692469 — intervention group
Group type: EXPERIMENTAL
Intervention: temazepam 15 mg
Number of subjects: 23
Study 14692469 — intervention group
Group type: EXPERIMENTAL
Intervention: melatonin 6 mg
Number of subjects: 23
Study 14692469 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study 10791665 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 84
Study 10791665 — intervention group
Group type: COMPARATOR
Intervention: Compression plating (PLT)
Number of subjects: 84
Study 8821299 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM allergen measurement using monoclonal antibody enzyme linked immunosorbent assay (ELISA)
Number of subjects: 215
Study 8821299 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM allergen measurement
Number of subjects: 215
Study 2119555 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fibronectin (7.5 mg.kg‐1.d‐1 for 4 days)
Number of subjects: 72
Study 2119555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 6988304 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone therapy
Number of subjects: 44
Study 6988304 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 44
Study 30928884 — intervention group
Group type: EXPERIMENTAL
Intervention: MABT (Mindful Awareness in Body‐oriented Therapy)
Number of subjects: 187
Study 30928884 — intervention group
Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 187
Study 30928884 — intervention group
Group type: COMPARATOR
Intervention: WHE (Women's Health Education)
Number of subjects: 187
Study 27627630 — intervention group
Group type: EXPERIMENTAL
Intervention: brief remoralization treatment
Number of subjects: 78
Study 27627630 — intervention group
Group type: EXPERIMENTAL
Intervention: brief exposure treatment
Number of subjects: 78
Study 27627630 — intervention group
Group type: COMPARATOR
Intervention: waiting list (WL)
Number of subjects: 78
Study 25986854 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 9521
Study 25986854 — intervention group
Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy alone (SLNB)
Number of subjects: 9521
Study 23636445 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO criteria for gestational diabetes mellitus (GDM)
Number of subjects: 0
Study 23636445 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified IADPSG criteria for gestational diabetes mellitus (GDM)
Number of subjects: 0
Study 23636445 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight gain in pregnancy
Number of subjects: 0
Study 23636445 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal weight loss post-partum
Number of subjects: 0
Study 21247480 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA analysis, family history of CD and smoking status
Number of subjects: 470
Study 21247480 — intervention group
Group type: COMPARATOR
Intervention: Family history of CD and smoking status
Number of subjects: 470
Study 19695525 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation exercises (resistance training, flexibility, step training) 3 times per week before TKA
Number of subjects: 54
Study 19695525 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 54
Study 17944603 — intervention group
Group type: EXPERIMENTAL
Intervention: Various performance assessment methods
Number of subjects: 0
Study 17944603 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-method strategy for performance assessment
Number of subjects: 0
Study 15212867 — intervention group
Group type: EXPERIMENTAL
Intervention: Care co-ordination (CC) program involving care planning by a general practitioner (GP) and graduated case management.
Number of subjects: 2742
Study 15212867 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 2742
Study 15212867 — intervention group
Group type: EXPERIMENTAL
Intervention: Care co-ordination (CC) program
Number of subjects: 2742
Study 11171680 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued methotrexate treatment (group A)
Number of subjects: 388
Study 11171680 — intervention group
Group type: COMPARATOR
Intervention: Discontinued methotrexate treatment (group B)
Number of subjects: 388
Study 11171680 — intervention group
Group type: COMPARATOR
Intervention: No methotrexate treatment (group C)
Number of subjects: 388
Study 9764335 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate with mefloquine (25 mg/kg)
Number of subjects: 100
Study 9764335 — intervention group
Group type: COMPARATOR
Intervention: Artesunate alone
Number of subjects: 100
Study 8043556 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestogens
Number of subjects: 0
Study 8043556 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives
Number of subjects: 0
Study 8043556 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin synthetase inhibitors
Number of subjects: 0
Study 8043556 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifibrinolytic drugs
Number of subjects: 0
Study 8043556 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotrophin-releasing hormone analogues
Number of subjects: 0
Study 8043556 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 0
Study 3061354 — intervention group
Group type: EXPERIMENTAL
Intervention: Jelonet and Whitehead's varnish (compound iodoform paint BPC)
Number of subjects: 40
Study 3061354 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing of Jelonet, gauze, wool and a crêpe bandage
Number of subjects: 40
Study 29267519 — intervention group
Group type: COMPARATOR
Intervention: 400mg Ibuprofen 60 min preemptive + 400mg Ibuprofen postoperative
Number of subjects: 20
Study 29267519 — intervention group
Group type: EXPERIMENTAL
Intervention: 4mg Dexamethasone 60 min preemptive + 4mg Dexamethasone postoperative
Number of subjects: 20
Study 26645254 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN, 5 mg/d for 7 days)
Number of subjects: 629
Study 26645254 — intervention group
Group type: COMPARATOR
Intervention: No GTN (control)
Number of subjects: 629
Study 26645254 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN) in patients randomized within 6 hours
Number of subjects: 629
Study 25268838 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 FA‐enriched oral nutritional supplement (ONS) providing 2.0 g of eicosapentaenoic acid (EPA) and 1.0 g of docosahexaenoic acid (DHA) per day
Number of subjects: 148
Study 25268838 — intervention group
Group type: COMPARATOR
Intervention: standard ONS
Number of subjects: 148
Study 23830725 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunflower oil massage
Number of subjects: 54
Study 23830725 — intervention group
Group type: COMPARATOR
Intervention: Body massage alone
Number of subjects: 54
Study 20369615 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril with Propranolol
Number of subjects: 42
Study 20369615 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril with Cytomack
Number of subjects: 42
Study 18972730 — intervention group
Group type: EXPERIMENTAL
Intervention: Small needle-knife comprehensive therapy
Number of subjects: 305
Study 18972730 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 305
Study 17010793 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 9978
Study 17010793 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 9978
Study 17010793 — intervention group
Group type: EXPERIMENTAL
Intervention: No pretreatment
Number of subjects: 9978
Study 17010793 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent therapy with enoxaparin
Number of subjects: 9978
Study 14572425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (nutrition sessions and written materials)
Number of subjects: 1055
Study 14572425 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 1055
Study 11090807 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular pacing
Number of subjects: 13
Study 11090807 — intervention group
Group type: COMPARATOR
Intervention: Sinus rhythm or right ventricular pacing
Number of subjects: 13
Study 8958418 — intervention group
Group type: COMPARATOR
Intervention: tissue plasminogen activator (t-PA)
Number of subjects: 395
Study 8958418 — intervention group
Group type: EXPERIMENTAL
Intervention: primary percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 395
Study 1302750 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimuliv (2 tablets thrice daily)
Number of subjects: 145
Study 1302750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 1302750 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimuliv
Number of subjects: 145
Study 3924553 — intervention group
Group type: EXPERIMENTAL
Intervention: acarbose (3 X 100 mg/day)
Number of subjects: 9
Study 3924553 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study 31262265 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca block using 30 ml of bupivacaine 0.5% with epinephrine 1:200,000
Number of subjects: 30
Study 31262265 — intervention group
Group type: COMPARATOR
Intervention: Sham injection with normal saline
Number of subjects: 30
Study 30152645 — intervention group
Group type: EXPERIMENTAL
Intervention: VNS + TAU
Number of subjects: 599
Study 30152645 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 599
Study 26829251 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS/Candesartan combination therapy (N: 20, 30, or 60 mg; C: 4, 8, 16, or 32 mg daily)
Number of subjects: 1362
Study 26829251 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine monotherapy
Number of subjects: 1362
Study 26829251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1362
Study 26829251 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS/Candesartan combination therapy
Number of subjects: 1362
Study 24184617 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric stabilization exercises
Number of subjects: 39
Study 24184617 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic stabilization exercises
Number of subjects: 39
Study 24184617 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 39
Study 22699818 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine (L-T4) treatment for 24 months
Number of subjects: 161
Study 22699818 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 161
Study 20227168 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative pelvic floor muscle exercise (PFME)
Number of subjects: 118
Study 20227168 — intervention group
Group type: COMPARATOR
Intervention: Postoperative pelvic floor muscle exercise (PFME)
Number of subjects: 118
Study 20227168 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative PFME
Number of subjects: 118
Study 17106274 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 237
Study 17106274 — intervention group
Group type: COMPARATOR
Intervention: Stavudine
Number of subjects: 237
Study 16323716 — intervention group
Group type: EXPERIMENTAL
Intervention: 188Re‐HEDP (3194 +/‐ 387 MBq)
Number of subjects: 64
Study 16323716 — intervention group
Group type: EXPERIMENTAL
Intervention: 186Re‐HEDP (1358 +/‐ 158 MBq)
Number of subjects: 64
Study 16323716 — intervention group
Group type: EXPERIMENTAL
Intervention: 89Sr (152 +/‐ 19 MBq)
Number of subjects: 64
Study 11856082 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg ridogrel once daily
Number of subjects: 0
Study 11856082 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg ridogrel once daily
Number of subjects: 0
Study 11856082 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg ridogrel once daily
Number of subjects: 0
Study 11856082 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11856082 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg ridogrel once daily (International trial)
Number of subjects: 0
Study 11856082 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg ridogrel once daily (International trial)
Number of subjects: 0
Study 11856082 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg ridogrel once daily (International trial)
Number of subjects: 0
Study 11856082 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine 800 mg three times daily (International trial)
Number of subjects: 0
Study 9660334 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of anorganic bovine-derived hydroxyapatite matrix (ABM) and cell binding peptide (P-15)
Number of subjects: 31
Study 9660334 — intervention group
Group type: COMPARATOR
Intervention: Demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 31
Study 9660334 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement (DEBR)
Number of subjects: 31
Study 8617528 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone (7.5 mg/kg/day)
Number of subjects: 72
Study 8617528 — intervention group
Group type: COMPARATOR
Intervention: Nalidixic acid (55 mg/kg/day)
Number of subjects: 72
Study 2534412 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide treatment
Number of subjects: 20
Study 2534412 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study 29147854 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 600
Study 29147854 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine
Number of subjects: 600
Study 29147854 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 600
Study 28963303 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 64
Study 28963303 — intervention group
Group type: COMPARATOR
Intervention: Dietary weight loss programme
Number of subjects: 64
Study 26302784 — intervention group
Group type: EXPERIMENTAL
Intervention: 6‐h postoperative clamped suction tube drainage
Number of subjects: 44
Study 26302784 — intervention group
Group type: COMPARATOR
Intervention: Non‐clamped suction tube drainage
Number of subjects: 44
Study 23160977 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 kVp protocol with 50% reduced contrast (185 mgI/kg)
Number of subjects: 68
Study 23160977 — intervention group
Group type: COMPARATOR
Intervention: 120 kVp protocol with standard contrast (370 mgI/kg)
Number of subjects: 68
Study 23160977 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 kVp with hybrid-iterative reconstruction
Number of subjects: 68
Study 20610085 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05%
Number of subjects: 14
Study 20610085 — intervention group
Group type: COMPARATOR
Intervention: Artificial tear
Number of subjects: 14
Study 19100929 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple airway (TA)
Number of subjects: 40
Study 19100929 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw thrust with teeth protrusion (JTP)
Number of subjects: 40
Study 19100929 — intervention group
Group type: EXPERIMENTAL
Intervention: Head tilt with chin lift (HT)
Number of subjects: 40
Study 19100929 — intervention group
Group type: EXPERIMENTAL
Intervention: Original airway position (OA)
Number of subjects: 40
Study 16645545 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated equine estrogens (CEE) and 2.5 mg of medroxyprogesterone acetate (MPA) daily
Number of subjects: 73
Study 16645545 — intervention group
Group type: COMPARATOR
Intervention: 0.625 mg of conjugated equine estrogens (CEE) and 2.5 mg of medroxyprogesterone acetate (MPA) on alternate days
Number of subjects: 73
Study 16645545 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups receiving HT
Number of subjects: 73
Study 12818283 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 39
Study 12818283 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 39
Study 10958375 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation for 1 week in vegetarians (VC) and meat-eaters (MC)
Number of subjects: 0
Study 10958375 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation in meat-eaters (MC)
Number of subjects: 0
Study 10958375 — intervention group
Group type: COMPARATOR
Intervention: Control group (glucose only, MG)
Number of subjects: 0
Study 8851828 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% isobaric mepivacaine
Number of subjects: 90
Study 8851828 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine
Number of subjects: 90
Study 8851828 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% isobaric bupivacaine with adrenalin
Number of subjects: 90
Study 1993037 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy (325 mg on alternate days)
Number of subjects: 22071
Study 1993037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22071
Study 1993037 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy (325 mg on alternate days) among younger men (aged 40 to 59 years)
Number of subjects: 22071
Study 6224001 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% octenidine in vehicle
Number of subjects: 60
Study 6224001 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% octenidine in aqueous solution
Number of subjects: 60
Study 6224001 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% octenidine in vehicle
Number of subjects: 60
Study 6224001 — intervention group
Group type: COMPARATOR
Intervention: vehicle only
Number of subjects: 60
Study 31353819 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (NSPT) with preparatory 15-day decontamination phase including chlorhexidine mouth rinse and domiciliary hygiene instructions (modified FMD: test group)
Number of subjects: 60
Study 31353819 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical periodontal therapy (NSPT) without preparatory decontamination (FMD: control group)
Number of subjects: 60
Study 31353819 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (NSPT) with modified FMD (test group)
Number of subjects: 60
Study 28632508 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine with transcranial direct current stimulation and speech and language therapy
Number of subjects: 10
Study 28632508 — intervention group
Group type: COMPARATOR
Intervention: Placebo with transcranial direct current stimulation and speech and language therapy
Number of subjects: 10
Study 26944818 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV)
Number of subjects: 28
Study 26944818 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 28
Study 25109699 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN treatment for 1 year
Number of subjects: 262
Study 25109699 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA‐DPB1 polymorphisms
Number of subjects: 262
Study 25109699 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA‐DPB1 G-allele
Number of subjects: 262
Study 25109699 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA‐DPA1 and HLA‐DPB1 haplotype block GG
Number of subjects: 262